56 related articles for article (PubMed ID: 24941362)
1. The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia.
Gibert J; Giner J; Bobes J; Tafalla M; Herranz S; Ovejero C; Rico-Villademoros F; For The Sos Group 1 ; Gibert J; Giner J; Bobes J; Tafalla M; Herranz S; Ovejero C; Rico-Villademoros F; For The Sos Group 1
Int J Psychiatry Clin Pract; 2007; 11(3):222-32. PubMed ID: 24941362
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Buckley PF
Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics.
De Nayer A; Windhager E; Irmansyah ; Larmo I; Lindenbauer B; Rittmannsberger H; Platz T; Jones A; Whiteford J; Altman C
Int J Psychiatry Clin Pract; 2003; 7(1):59-66. PubMed ID: 24937244
[TBL] [Abstract][Full Text] [Related]
4. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
György B; Robert K; László C; Andrea J;
Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine in combination with citalopram in patients with unipolar psychotic depression.
Konstantinidis A; Hrubos W; Nirnberger G; Windhager E; Lehofer M; Aschauer H; Kasper S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):242-7. PubMed ID: 16962224
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of quetiapine for the management of aggressive psychosis in the emergency psychiatric setting: a naturalistic uncontrolled trial.
Ganesan S; Levy M; Bilsker D; Khanbhai I
Int J Psychiatry Clin Pract; 2005; 9(3):199-203. PubMed ID: 24937791
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine demonstrates good tolerability and is associated with improvements in extrapyramidal symptoms in patients with schizophrenia switched from other antipsychotics: results of a naturalistic study.
Hellewell JS
Int J Psychiatry Clin Pract; 2007; 11(2):112-22. PubMed ID: 24937556
[TBL] [Abstract][Full Text] [Related]
8. An open multicentre pilot study examining the safety, efficacy and tolerability of fast titrated (800 mg/day by day 4) quetiapine in the treatment of schizophrenia/schizoaffective disorder.
Peuskens J; Devoitille JM; Kusters J; Vandenhoven G
Int J Psychiatry Clin Pract; 2008; 12(4):261-7. PubMed ID: 24937712
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study.
Maciulis V; Bitter I; Milasiunas R; Dembinskas A; Radavicius L; Kaunas A; Dossenbach M; Walker D
Curr Ther Res Clin Exp; 2004 Jan; 65(1):57-69. PubMed ID: 24936104
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
McManus DQ; Arvanitis LA; Kowalcyk BB
J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
Lee KU; Jeon YW; Lee HK; Jun TY
Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
[TBL] [Abstract][Full Text] [Related]
12. The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia.
Chue P; Malla A; Bouchard RH; Lessard S; Ganesan S; Stip E; Johnson S; Chen E; Ahn YM; Kim YS; Robinson G; Schweikert C; Gendron A; Eriksson H;
Curr Med Res Opin; 2013 Mar; 29(3):227-39. PubMed ID: 23281876
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety and tolerability of quetiapine: short-term high doses with long-term follow-up.
Nagy J
Int J Psychiatry Clin Pract; 2005; 9(1):16-21. PubMed ID: 24945332
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness, tolerability and subjective well-being in patients receiving quetiapine: findings of a post-marketing surveillance study in schizophrenia.
Lambert M; Reimitz PE; Naber D
Int J Psychiatry Clin Pract; 2006; 10(3):204-12. PubMed ID: 24941059
[TBL] [Abstract][Full Text] [Related]
15. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
Ratner Y; Gibel A; Yorkov V; Ritsner MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1401-9. PubMed ID: 17669574
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine in schizophrenia: onset of action within the first week of treatment.
Small JG; Kolar MC; Kellams JJ
Curr Med Res Opin; 2004 Jul; 20(7):1017-23. PubMed ID: 15265246
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of quetiapine for treatment of geriatric psychosis.
Yang CH; Tsai SJ; Hwang JP
J Psychopharmacol; 2005 Nov; 19(6):661-6. PubMed ID: 16272189
[TBL] [Abstract][Full Text] [Related]
19. Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study.
Kim Y; Wang SM; Kwak KP; Yoon HK; Pae CU; Kim JJ; Bahk WM
Clin Psychopharmacol Neurosci; 2016 Nov; 14(4):371-377. PubMed ID: 27776390
[TBL] [Abstract][Full Text] [Related]
20. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
